Literature DB >> 29314126

Editorial: NAFLD-related hepatocellular carcinoma - increasing or not? With or without cirrhosis?

M Balakrishnan1, H B El-Serag1,2,3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29314126      PMCID： PMC5765763          DOI： 10.1111/apt.14464

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  9 in total

Review 1.  Hepatitis C virus infection, antiviral therapy, and risk of hepatocellular carcinoma.

Authors:  Yao-Chun Hsu; Chun-Ying Wu; Jaw-Town Lin
Journal:  Semin Oncol       Date:  2014-12-31       Impact factor: 4.929

2.  Trends in the Burden of Nonalcoholic Fatty Liver Disease in a United States Cohort of Veterans.

Authors:  Fasiha Kanwal; Jennifer R Kramer; Zhigang Duan; Xiaoying Yu; Donna White; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2015-08-17       Impact factor: 11.382

3.  Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population.

Authors:  Sahil Mittal; Yvonne H Sada; Hashem B El-Serag; Fasiha Kanwal; Zhigang Duan; Sarah Temple; Sarah B May; Jennifer R Kramer; Peter A Richardson; Jessica A Davila
Journal:  Clin Gastroenterol Hepatol       Date:  2014-08-19       Impact factor: 11.382

4.  Nucleos(t)ide analogues associated with a reduced risk of hepatocellular carcinoma in hepatitis B patients: a population-based cohort study.

Authors:  Jack P Wang; Feng-Yu Kao; Chen-Yi Wu; Yi-Ping Hung; Yee Chao; Yiing-Jenq Chou; Chung-Pin Li
Journal:  Cancer       Date:  2014-12-23       Impact factor: 6.860

5.  Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans is Associated With Nonalcoholic Fatty Liver Disease.

Authors:  Sahil Mittal; Hashem B El-Serag; Yvonne H Sada; Fasiha Kanwal; Zhigang Duan; Sarah Temple; Sarah B May; Jennifer R Kramer; Peter A Richardson; Jessica A Davila
Journal:  Clin Gastroenterol Hepatol       Date:  2015-07-18       Impact factor: 11.382

6.  Temporal trends, clinical patterns and outcomes of NAFLD-related HCC in patients undergoing liver resection over a 20-year period.

Authors:  R Pais; L Fartoux; C Goumard; O Scatton; D Wendum; O Rosmorduc; V Ratziu
Journal:  Aliment Pharmacol Ther       Date:  2017-08-31       Impact factor: 8.171

Review 7.  Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review.

Authors:  Donna L White; Fasiha Kanwal; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2012-10-04       Impact factor: 11.382

8.  Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States.

Authors:  Tania M Welzel; Barry I Graubard; Sabah Quraishi; Stefan Zeuzem; Jessica A Davila; Hashem B El-Serag; Katherine A McGlynn
Journal:  Am J Gastroenterol       Date:  2013-06-11       Impact factor: 10.864

9.  Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.

Authors:  Robert J Wong; Ramsey Cheung; Aijaz Ahmed
Journal:  Hepatology       Date:  2014-04-25       Impact factor: 17.425
  9 in total
  1 in total

Review 1.  Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review.

Authors:  Aakash Desai; Sonia Sandhu; Jin-Ping Lai; Dalbir Singh Sandhu
Journal:  World J Hepatol       Date:  2019-01-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.